Suppr超能文献

[意大利心律学与心脏起搏协会起搏器及植入式心脏复律除颤器注册中心——2016年年报]

[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2016].

作者信息

Proclemer Alessandro, Zecchin Massimo, D'Onofrio Antonio, Boriani Giuseppe, Facchin Domenico, Rebellato Luca, Ghidina Marco, Bianco Giulia, Bernardelli Emanuela, Pucher Elsa, Gregori Dario

机构信息

S.O.C. Cardiologia e Fondazione IRCAB, Azienda Sanitaria Universitaria Integrata S. Maria della Misericordia, Udine.

S.O.C. Cardiologia, Azienda Sanitaria Universitaria Integrata, Trieste.

出版信息

G Ital Cardiol (Rome). 2018 Feb;19(2):119-131. doi: 10.1714/2868.28944.

Abstract

BACKGROUND

The pacemaker (PM) and implantable cardioverter-defibrillator (ICD) registry of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) monitors the main epidemiological data in real-world practice. The survey for the 2016 activity collects information about demographics, clinical characteristics, main indications for PM/ICD therapy and device types from the Italian collaborating centers.

METHODS

The registry collects prospectively national PM and ICD implantation activity on the basis of European cards.

RESULTS

PM Registry: data about 23 496 PM implantations were collected (19 003 first implant and 4493 replacements). The number of collaborating centers was 204. Median age of treated patients was 81 years (75 quartile I; 86 quartile III). ECG indications included atrioventricular conduction disorders in 39.8% of first PM implants, sick sinus syndrome in 22.1%, atrial fibrillation plus bradycardia in 14.1%, other in 24.0%. Among atrioventricular conduction defects, third-degree atrioventricular block was the most common type (22.18% of first implants). Use of single-chamber PMs was reported in 26.9% of first implants, of dual-chamber PMs in 65.0%, of PMs with cardiac resynchronization therapy (CRT) in 1.5%, and of single lead atrial-synchronized ventricular stimulation (VDD/R PMs) in 6.6%. ICD Registry: data about 20 350 ICD implantations were collected (14 763 first implants and 5587 replacements). The number of collaborating centers was 430. Median age of treated patients was 72 years (63 quartile I; 78 quartile III]. Primary prevention indication was reported in 79.0% of first implants, secondary prevention in 21.0% (cardiac arrest in 7.9%). A single-chamber ICD was used in 32.2% of first implants, dual-chamber in 31.1% and biventricular in 36.7%.

CONCLUSIONS

The PM and ICD Registry appears fundamental for monitoring PM and ICD utilization on a large national scale with rigorous examination of demographics and clinical indications. The PM Registry showed stable electrocardiographic and symptom indications, with an important prevalence of dual-chamber pacing. The use of CRT-PM regards a very limited number of patients. The ICD Registry documented a large use of prophylactic and biventricular ICD, reflecting a favorable adherence to trials and guidelines in clinical practice.

摘要

背景

意大利心律失常与心脏起搏协会(AIAC)的起搏器(PM)和植入式心律转复除颤器(ICD)注册系统监测现实世界中的主要流行病学数据。2016年的调查从意大利的合作中心收集了有关人口统计学、临床特征、PM/ICD治疗的主要适应证和设备类型的信息。

方法

该注册系统根据欧洲卡片前瞻性地收集全国PM和ICD植入活动的数据。

结果

PM注册系统:收集了23496例PM植入的数据(19003例首次植入和4493例更换)。合作中心有204个。接受治疗患者的中位年龄为81岁(四分位数I为75岁;四分位数III为86岁)。心电图适应证包括首次PM植入中39.8%的房室传导障碍、22.1%的病态窦房结综合征、14.1%的心房颤动合并心动过缓、24.0%的其他情况。在房室传导缺陷中,三度房室传导阻滞是最常见的类型(首次植入的22.18%)。首次植入中报告使用单腔PM的占26.9%,双腔PM的占65.0%,心脏再同步治疗(CRT)PM的占1.5%,单导联心房同步心室刺激(VDD/R PM)的占6.6%。ICD注册系统:收集了20350例ICD植入的数据(14763例首次植入和5587例更换)。合作中心有430个。接受治疗患者的中位年龄为72岁(四分位数I为63岁;四分位数III为78岁)。首次植入中79.0%报告为一级预防适应证,21.0%为二级预防(心脏骤停占7.9%)。首次植入中32.2%使用单腔ICD,31.1%使用双腔ICD,36.7%使用双心室ICD。

结论

PM和ICD注册系统对于在全国范围内大规模监测PM和ICD的使用情况以及严格审查人口统计学和临床适应证似乎至关重要。PM注册系统显示心电图和症状适应证稳定,双腔起搏的患病率较高。CRT-PM的使用涉及的患者数量非常有限。ICD注册系统记录了预防性和双心室ICD的大量使用,反映了在临床实践中对试验和指南的良好遵循情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验